for the period from January 1 to December 31, 2023
|
|
Note |
2023 |
2022 |
|---|---|---|---|---|
Net profit/loss after tax |
|
(592,953) |
(37,241) |
|
+ |
Amortization of intangible assets, depreciation of property, plant and equipment and right-of-use assets and depletion of biological assets |
781,771 |
227,589 |
|
+/– |
Change in the fair value of biological assets |
(80,102) |
(17,009) |
|
– |
Income from the release of investment grants |
|
(2,025) |
(2,126) |
+/– |
Change in non-current provisions |
|
(2,050) |
(13,162) |
–/+ |
Income/expense from deferred taxes |
|
(62,895) |
(5,579) |
+/– |
Change in current tax assets and liabilities |
|
50,236 |
(15,495) |
+/– |
Income from investments accounted for using the equity method |
|
(4,048) |
1,062 |
–/+ |
Other non-cash income/expenses |
553 |
106,743 |
|
Gross cash flow |
|
88,488 |
244,783 |
|
|
|
|
|
|
+/– |
Change in inventories |
|
178,245 |
(295,952) |
+/– |
Change in receivables |
|
34,751 |
10,581 |
+/– |
Change in liabilities |
|
(141,160) |
(2,657) |
Change in working capital |
|
71,836 |
(288,028) |
|
Cash flow from operating activities |
|
160,323 |
(43,246) |
|
|
|
|
|
|
– |
Acquisition of intangible assets, property, plant and equipment and biological assets |
|
(267,834) |
(698,894) |
– |
Acquisition of corporate units |
(15,731) |
0 |
|
– |
Acquisition/Disbursement of financial assets and investments accounted for using the equity method |
|
(14,225) |
(303) |
+ |
Proceeds from the sale of intangible assets, property, plant and equipment and biological assets |
|
436 |
1,443 |
+ |
Proceeds from the sale/repayment of financial assets and the sale of investments accounted for using the equity method |
|
5,846 |
10,368 |
Cash flow from investing activities |
|
(291,509) |
(687,387) |
|
|
|
|
|
|
+ |
Cash proceeds from issuing shares |
392,069 |
0 |
|
+ |
Capital injections to consolidated companies by non-controlling interests |
|
0 |
56,673 |
– |
Dividends paid (including hybrid coupon) |
(29,000) |
(144,393) |
|
+ |
Investment grants |
|
1,616 |
1,469 |
+ |
Increase in other financial liabilities |
226,640 |
258,907 |
|
– |
Repayment of bonds and private placements |
0 |
(72,000) |
|
– |
Repayment of other financial liabilities |
(170,232) |
(46,601) |
|
Cash flow from financing activities |
|
421,094 |
54,056 |
|
|
|
|
|
|
Total change in liquid funds |
|
289,908 |
(676,576) |
|
|
|
|
|
|
Liquid funds at the beginning of the year |
|
446,873 |
1,113,279 |
|
Currency translation adjustment relating to liquid funds |
|
(11,142) |
10,170 |
|
Liquid funds at the end of the year |
|
725,639 |
446,873 |
|
|
|
|
|
|
Additional information on payments in the cash flow from operating activities: |
|
|
|
|
Interest payments received |
|
15,262 |
10,756 |
|
Interest payments made |
|
120,409 |
74,631 |
|
Income taxes paid |
|
15,770 |
48,474 |
|
Distributions received from investments accounted for using the equity method |
|
2,680 |
840 |
|